A report in the journal Blood finds 11 of 12 cancer drugs approved by the FDA last year cost more than $100,000 annually, making it difficult for patients to obtain treatment for conditions such as chronic myeloid leukemia. It's part of a broader trend of high-cost treatments, researchers noted, reporting that the mean monthly cost of cancer drugs overall has increased from $5,000 to more than $10,000 in the past decade. More than 100 of the world's leading cancer specialists urged drug companies to address the issue, arguing that the prices are unsustainable. "Advocating for lower drug prices is a necessity to save the lives of patients," they wrote.
Oncologists call for reduction in drug prices
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|